MATTHEW E. GARTH - 30 May 2025 Form 4 Insider Report for DENTSPLY SIRONA Inc. (XRAY)

Role
EVP & CFO
Signature
/s/ Jessica Causey, Attorney-in-Fact for Matthew E. Garth
Issuer symbol
XRAY
Transactions as of
30 May 2025
Net transactions value
$0
Form type
4
Filing time
03 Jun 2025, 16:48:31 UTC
Previous filing
12 Dec 2024
Next filing
15 Jul 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
GARTH MATTHEW E EVP & CFO C/O DENTSPLY SIRONA INC, 13320-B BALLANTYNE CORPORATE PLACE, CHARLOTTE /s/ Jessica Causey, Attorney-in-Fact for Matthew E. Garth 03 Jun 2025 0001695300

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction XRAY Common Stock Award $0 +43,023 $0.000000 43,023 30 May 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction XRAY Stock Option (Right to Buy) Award $0 +173,800 $0.000000 173,800 30 May 2025 Common Stock 173,800 $15.98 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Award consists entirely of Restricted Stock Units (RSUs) which vest in annual one-third (1/3) increments over a three-year period ending May 30, 2028.
F2 Stock Options vest in annual one-third (1/3) increments over a three-year period ending May 30, 2028.